WIXELA INHUB 250/50 is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. WIXELA INHUB 250/50 is also indicated to reduce exacerbations of COPD in patients with a history of exacerbations.

2024年1月17日 · It is used to treat asthma. Some brands are used to treat COPD (chronic obstructive pulmonary disease). It may be given to you for other reasons. Talk with the doctor. This medicine is not to be used to treat intense flare-ups of shortness of breath. Use a rescue inhaler. Talk with the doctor.

2023年12月19日 · Wixela Inhub is a combination inhaler that contains fluticasone (an inhaled corticosteroid) and salmeterol (a long-acting beta agonist, or LABA). This medication is used as maintenance treatment of chronic obstructive pulmonary disease …

2024年10月23日 · How to Use an Inhub Inhaler Proper inhaler device technique is important when taking your medicine(s) and monitoring your breathing. Learn the correct way to use your Inhub Inhaler.

2024年9月29日 · Overview: Fluticasone/salmeterol is a powder or spray that you inhale to help manage breathing problems, such as asthma or chronic obstructive pulmonary disease (COPD). It...

Treatment of asthma in patients aged 12 years and older: 1 inhalation of Wixela Inhub ® 100/50, Wixela Inhub ® 250/50, or Wixela Inhub ® 500/50 twice daily. Starting dosage is based on asthma severity. (2.1)

2025年2月4日 · Wixela Inhub is an FDA-approved inhaler containing fluticasone and salmeterol. It’s commonly prescribed for the long-term treatment of asthma and COPD in adults and children. As a powder-based inhaler, it offers a cost-effective alternative to Advair while delivering the same active ingredients and similar benefits.

Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) indicated for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obs...

Inhale this medication by mouth as directed by your doctor, usually twice daily (in the morning and evening, 12 hours apart). You may or may not taste/feel the drug when you inhale. Either is normal. Do not exhale into the device. Do not take the inhaler apart or wash the mouthpiece or any part of the device. Close the device after each use.

Wixela Inhub is a new dry powder inhaler that includes the medicines fluticasone and salmeterol. The inhaler is often used for treating asthma or COPD. For more information, please see the Wixela Inhub Infographic and the patient education training video, How to Use the Wixela Inhub.